Skip to content

Investigator

Shaomeng Wang

UNIVERSITY OF MICHIGAN AT ANN ARBOR · funded by NCI

Companies
1

Resolved onto their grants.

Grants
3

Federal awards on file.

Non-dilutive funding
$2.0M

Summed across those awards.

First award
Sep 1, 2023

Latest Mar 1, 2024.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    Orally active CBP/p300 degraders

    $673k

    Mar 1, 2024NCIUNIVERSITY OF MICHIGAN AT ANN ARBORNIH RePORTER · 11046643 (opens the source filing in a new tab)

  2. R01

    Orally active CBP/p300 degraders

    $656k

    Mar 1, 2024NCIUNIVERSITY OF MICHIGAN AT ANN ARBORNIH RePORTER · 11294285 (opens the source filing in a new tab)

  3. R01

    Small-molecule degraders of STAT5

    $647k

    Sep 1, 2023NCIUNIVERSITY OF MICHIGAN AT ANN ARBORNIH RePORTER · 11162336 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources